Basel, Switzerland, 2007/01/30
Swiss-based computational biology firm Genedata announces the release of Genedata Expressionist® Pro 4.0, a fully scalable data management and analysis platform for biomarker discovery. Uniquely, Expressionist integrates cross-omics technologies within a single enterprise-wide computational system.
A major challenge in biomarker discovery is the integration of a variety of omics data, including transcript profiles generated from different microarray technologies, and protein and metabolite profiles obtained from mass-spectrometry technologies. These data must be combined to understand biological processes at different functional levels. The Expressionist platform automates the integration process and standardizes the way results are placed in scientific context.
Expressionist now also supports the Illumina technology platform. This enables a combined analysis of microarray data, for example Illumina and Affymetrix arrays, as well as mass spectrometry data. The system is supported by a fully integrated relational database system and by APIs to integrate third party algorithms (for example R scripts).
Expressionist facilitates a complete workflow from data quality assurance to biological interpretation. Within the Expressionist analysis workflow, users will also be able to annotate their results with GeneGo’s Metacore and with Ingenuity Pathway Analysis system.
Biomarker discovery has become an important component for cost-efficient safety and efficacy prediction in preclinical development. “We have strengthened Expressionist to support our growing customer base in Europe, US and Asia for biomarker discovery in toxicogenomics, pharmacogenomics and diagnostics”, explained Dr. Othmar Pfannes, CEO of Genedata AG.
Contact:
Genedata AG
Dr Tobe Freeman
Manager Public Relations
Phone +41 61 697 8510
Fax +41 61 697 7244
Tobe.Freeman@genedata.com
www.genedata.com
Genedata specializes in discovery informatics for biotech, pharmaceuticals and the life sciences. The Company offers expertise in research informatics combined with open and scalable computational solutions. Our solutions include Genedata Phylosopher® for integrating, structuring, and analyzing research data. Genedata Screener® for high throughput screening analysis. And Genedata Expressionist® for omics data integration, processing and analysis. Founded in 1997 as a privately held spin off from Novartis, Genedata is headquartered in Basel, Switzerland and has branches in Munich (Germany), Boston (USA) and San Francisco (USA). The Company is also represented in Japan, Taiwan and Singapore. For more information about Genedata, please visit: www.genedata.com.
DisclaimerThe statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Related Files:
PDF version